Niacin/lovastatin how supplied storage and handling

Jump to navigation Jump to search
Niacin/lovastatin
ADVICOR® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Niacin/lovastatin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

How Supplied Storage and Handling

ADVICOR is an unscored capsule-shaped tablet containing either 500, 750, or 1000 mg of extended-release niacin, and 20 mg of immediate-release lovastatin (ADVICOR 500 mg/20 mg, 750 mg/20 mg, 1000 mg/20 mg), or 1000 mg of extended-release niacin and 40 mg of immediate-release lovastatin (ADVICOR 1000 mg/40 mg). Tablets are color-coated and printed with the “a” logo and a code number specific to the tablet strength on the same side. ADVICOR 500 mg/20 mg tablets are light yellow, code “502”. ADVICOR 750 mg/20 mg tablets are light orange, code “752”. ADVICOR 1000 mg/20 mg tablets are dark pink/light purple, code “1002”. ADVICOR 1000 mg/40 mg tablets are reddish brown, code “1004.” Tablets are supplied in bottles of 90 tablets as shown below.

500 mg/20 mg tablets: bottles of 90 - NDC# 0074-3005-90

750 mg/20 mg tablets: bottles of 90 - NDC# 0074-3072-90

1000 mg/20 mg tablets: bottles of 90 - NDC# 0074-3007-90

1000 mg/40 mg tablets: bottles of 90 - NDC# 0074-3010-90

Store at room temperature (20° to 25°C or 68° to 77°F).

NIASPAN is a registered trademark of AbbVie Inc., and Mevacor is a registered trademark of Merck & Co., Inc.[1]


References

  1. "ADVICOR (NIACIN AND LOVASTATIN) TABLET, EXTENDED RELEASE [ABBVIE INC.]". Retrieved 18 February 2014.

Template:Statins